Gilead Sciences: National Black HIV/AIDS Awareness Day

Feb 29, 2024 8:25 AM ET

Campaign: Corporate Social Responsibility

This year’s theme for National Black HIV/AIDS Awareness Day is “Engage, Educate, Empower: Uniting to End HIV/AIDS in Black Communities.” We spoke with C. Virginia Fields, President and CEO of National Black Leadership Commission on Health (Black Health), a Gilead grantee, about how together, we can take action toward meaningful change.

We commend Virginia and our many community partners for continuing to honor and advance the decades of progress that Black communities have made in HIV.

Learn more: https://gilead.inc/487PjBu

Gilead Sciences

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Gilead Sciences: National Black HIV/AIDS Awareness Day

More from Gilead Sciences

Gilead Sciences Publishes 2023 ESG Impact Report

Gilead Sciences Champions Equal Pay

Winn Awards Help Physicians Solve Healthcare Disparities

Gilead Helps Launch Türkiye’s First HIV Testing Week

Gilead Science Supports Increasing Diversity in Clinical Trials: 2024 Toward Health Equity Oncology Grant Supports 36 Global Organizations

Gilead Sciences Aids in Reducing Cancer Care Disparities: Dale Shares Her Breast Cancer Journey and the Power of Information Sharing

Gilead Sciences CEO on Company’s Evolution and Commitment to the Bay Area

Gilead Announces Funding Initiative To Support HIV Prevention, Anti-Stigma and Health Equity Efforts for Black Cisgender and Transgender Women and Girls in the U.S.